116 Folgen

  1. Risk of Parkinson Disease Among Camp Lejeune Veterans

    Vom: 15.5.2023
  2. Prenatal Exposure to Antiseizure Medication and Psychiatric Disorders

    Vom: 17.4.2023
  3. Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors

    Vom: 27.3.2023
  4. Optimal Intensity and Duration of Walking Rehabilitation in Patients With Chronic Stroke

    Vom: 23.2.2023
  5. Endovascular Thrombectomy vs Medical Management Beyond 24 Hours of Last Known Well

    Vom: 27.12.2022
  6. Autoimmune Encephalitis Misdiagnosis in Adults

    Vom: 28.11.2022
  7. Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease

    Vom: 31.10.2022
  8. Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During Pregnancy

    Vom: 26.9.2022
  9. Association of Neurocritical Care With Outcomes for Adults With Brain Injury

    Vom: 29.8.2022
  10. Efficacy of Benzodiazepines or Antihistamines for Patients With Acute Vertigo

    Vom: 18.7.2022
  11. A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief

    Vom: 5.7.2022
  12. Structural Inequities for Historically Underserved Communities in the Adoption of Stroke Certification in the US

    Vom: 27.6.2022
  13. Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

    Vom: 31.5.2022
  14. Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19

    Vom: 11.4.2022
  15. Early Posttraumatic Seizures and Moderate to Severe Traumatic Brain Injury

    Vom: 21.2.2022
  16. Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy

    Vom: 18.1.2022
  17. Assessment of Erenumab Safety and Efficacy in Migraine With and Without Aura

    Vom: 20.12.2021
  18. Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Probable Dementia With Lewy Bodies

    Vom: 22.11.2021
  19. Association of Increased Seizures During Rewarming With Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up

    Vom: 18.10.2021
  20. Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis

    Vom: 20.9.2021

2 / 6

Interviews with authors of articles from JAMA Neurology. JAMA Neurology is an international peer-reviewed journal for physicians caring for people with neurologic disorders and those interested in the structure and function of the normal and diseased nervous system.

Visit the podcast's native language site